ITM to Present at Upcoming Radiopharmaceutical Investor Conferences in New York City
Garching / Munich, September 19, 2024 – ITM Isotope Technologies Munich SE (ITM), a leading radiopharmaceutical biotech company, today announced...
Pharmaceutical
Basilea enters into agreement with BARDA to develop novel antifungals and antibacterials and receives initial funding
Initial funding of USD 29 million to support development of Basilea’s clinical stage first-in-class antifungals, fosmanogepix and BAL2062Multi-year Other Transaction...
U.S. grants Vidac Pharma patent offering broad protection of mode of action underlying its oncology drug candidates
London (UK), September 19 2024 – Vidac Pharma Holdings Plc. (Hamburg and Stuttgart: T9G; ISIN:GB00BM9XQ619; WKN: A3DTUQ), a clinical-stage oncology biopharmaceutical...
Positive phase III results show Xofluza significantly reduces the transmission of influenza viruses
Data from the CENTERSTONE study shows single-dose Xofluza reduces transmission of influenza from an infected person to household membersThis is...
Addex Provisional 2024 Half-Year and Second Quarter Result increased from a Net loss to a Net Profit
Ad Hoc Announcement Pursuant to Art. 53 LR Geneva, Switzerland, September 19, 2024 - Addex Therapeutics (SIX/NASDAQ: ADXN), a clinical-stage...
Cambrex Announces New Liquid-Phase Peptide Synthesis Manufacturing Technology
EAST RUTHERFORD, N.J., Sept. 19, 2024 /PRNewswire/ -- Cambrex, a leading global contract development and manufacturing organization (CDMO), today announced...
TFS HealthScience Unveils Mission to Empower Partners and Enrich Lives Worldwide
New messaging reflects TFS's commitment to patient-centered clinical research and global partnerships LUND, Sweden, Sept. 19, 2024 /PRNewswire/ -- TFS HealthScience...
Angle PLC Announces Agreement with Recursion Pharmaceuticals
New pharma agreement for Parsortix CTC analysisGUILDFORD, SURREY / ACCESSWIRE / September 19, 2024 / ANGLE plc (AIM:AGL)(OTCQX:ANPCY), a world-leading...
GE HealthCare announces cash dividend for third quarter of 2024
CHICAGO--(BUSINESS WIRE)--The Board of Directors of GE HealthCare Technologies Inc. (Nasdaq: GEHC) today declared a cash dividend of $0.03 per...
Cosmos Health Releases 2024-2027 Updated Guidance; Projects Revenue of $155.8M and Adjusted EBITDA of $29.4M Annually by 2027, Driven by Strategic Focus on High-Margin Segments
CHICAGO, IL / ACCESSWIRE / September 18, 2024 / Cosmos Health Inc. ("Cosmos Health" or the "Company'') (NASDAQ:COSM), a diversified,...
Nanocoatings Market Surges to USD 20.4 Billion by 2030, Propelled by 6.9% CAGR – Verified Market Reports®
The Nanocoatings market is driven by increasing demand across industries like automotive, electronics, and healthcare, where the coatings' enhanced durability,...
Live Cell Imaging Market Surges to USD 4.42 Billion by 2030, Propelled by 7.52% CAGR – Verified Market Reports®
The live cell imaging market is driven by advancements in cell biology research, increasing demand for high-content screening, and the...
OM1 Earns Frost & Sullivan’s 2024 North American New Product Innovation Award for Transforming Real-world Evidence Analytics Solutions Industry with Its Pioneering AI-powered Platforms
OM1's innovative solutions, such as Orion, Lyra, and Polaris, are revolutionizing patient journey analysis and clinical research through deep AI...
Deerfield Group Bolsters Marketing, Communications Leadership With New Senior Appointments
Strengthens Deerfield's award-winning marketing and communications leadership to deliver specialized solutions to clients at all stages of development and commercialization...
Ginkgo Bioworks Launches Ginkgo Datapoints to Transform AI Model Training in Biology
BOSTON, Sept. 18, 2024 /PRNewswire/ -- Today, Ginkgo Bioworks (NYSE: DNA), which is building the leading platform for cell programming and...
Ovia Health Expands Women’s Health Offerings with Comprehensive Postpartum Experience
New solution is the first holistic program available in a digital app to help women manage the postpartum period BOSTON,...
Procaps Issues Shareholder Letter Update
MIAMI and BARRANQUILLA, Colombia, Sept. 18, 2024 (GLOBE NEWSWIRE) -- Procaps Group, S.A. (NASDAQ: PROC) (“Procaps” or the “Company”), a...
Certara & Ichnos Glenmark Innovation Collaboration Optimizes Dosing Strategy for Potential First-In-Class Cancer Drug
Preclinical research on the trispecific antibody, ISB 2001, published in Nature Cancer leveraged virtual trials to select a higher starting dose...
BiomX to Provide Latest Update on Positive Phase 1b/2a Clinical Trial Data for BX004 at the North American Cystic Fibrosis Conference
GAITHERSBURG, Md., Sept. 18, 2024 (GLOBE NEWSWIRE) -- BiomX Inc. (NYSE American: PHGE) (“BiomX” or the “Company”), a clinical-stage company...
Tempest Further Strengthens Leadership Team with Appointment of Sheldon Mullins as Vice President, Regulatory Affairs
Company welcomes additional late-stage expertise as it prepares for amezalpat pivotal studyBRISBANE, Calif., Sept. 18, 2024 (GLOBE NEWSWIRE) -- Tempest...